Smart bioprocessing uses bioinformatics, lab-scale processing, and analytics to create efficient and cost-effective production processes that can be verified at lab-scale before scale-up.
Bioprocessing development is a long and costly process. Building in continuous characterization and connected bioprocessing cuts timelines and increases the available information through real-time analytics.
Using a case study, the author demonstrates how comparative statistical analysis enabled his team to improve the yield of a component used in API synthesis by more than 2.5 x 108 U/batch.
Read why Fibra-Cel disks are a promising alternative attachment matrix with a high surface-to- volume ratio and provide a three-dimensional environment that protects cells from damaging shear forces, helping to achieve high cell densities.
Parallel operation of multiple bioreactors and the use of single-use equipment can help reducing development times and ultimately costs.
Single‑use fermenters are becoming an increasingly viable alternative to stainless steel, offering less time is spent on equipment preparation and qualification prior to start-up as well as routine maintenance and requalification of the equipment.
Learn about polishing technologies that enable a fully flow through polishing platform and how implementation of next generation processing can positively impact facility fit limitations.
Explore the economic benefits when using a cell culture medium designed specifically for perfusion processes and the proactive risk measures suppliers need to take to facilitate the manufacturer’s business continuity and product quality.
A platform that combines drug development expertise and biomanufacturing and integrated services to offer advantages to ADC developers.
Using workflow based software solutions to guide scientists through various processes in low to high throughput screening campaigns.
In this webinar Joaquina Mascarenhas, Ph.D. of Milliporesigma will discuss the following...
Among the primary causes for attrition in early clinical development are safety and pharmacology issues. In the case of biopharmaceuticals, immunogenic and hypersensitivity reactions are perhaps the largest contributors to such early clinical failures
The Mobius® Power MIX 1000 and 2000 combine high performance mixing technology with design features that make them easy to use. The impeller design and motor are based on our magnetically coupled NovAseptic® mixing technology, a proven mixing technology in stainless steel tanks. The system efficiently mixes the most challenging buffers, media and biopharmaceutical ingredients.
For over 60 years, New Brunswick Shakers have been synonymous with quality construction and durability. They have been used in more labs the world over than any other shaker and our top-of-the line Innova models continue to be the market leaders.
Since their introduction over twenty years ago, Galaxy CO2 Incubators have become a mainstay in cell culture laboratories all over the world. They set the standard for advanced features and are designed to meet real world needs. They were first to use a fan-less design, direct heating technology and a seamless chamber. Time and again, features like these have helped to improve laboratory processes and cell culture results.